Systemic Lupus Erythematosus News

• Influential Long-time NIAMS Director Katz Dies at 77 Katz, who led the NIAMS since 1995, is remembered for his contributions to basic science, his willingness to take on thorny NIH management issues, and his exuberant, joyful personality.
  Medscape Medical News, December 2018
• AHA 2018'The Patient Has the Power' in New AHA/ACC Cholesterol Guideline If the 2013 guideline gave the ASCVD risk calculator too much power, as some held, the mostly well-received update restores it to patients and clinicians, with some left over for coronary calcium scans.
  Medscape Medical News, November 2018
• ACR 2018Daily Meditation Helps Arthritis Patient With Chronic Pain For one patient, meditation addresses the component of living with polyarthritis that medication does not.
  Medscape Medical News, October 2018
• ACR 2018Sexual Dysfunction Overlooked in Men With Lupus Lupus is uncommon in men and physicians could be missing opportunities to ask about sexual function during office visits.
  Medscape Medical News, October 2018
• Patients With Lupus Report More Flares, Different Symptoms Symptoms that patients with lupus experience might surprise some physicians, which can lead to communication challenges in the clinic, results from a patient survey suggest.
  Medscape Medical News, October 2018
• ACR 2018Checkpoint Inhibitors, Wearables Among Hot Topics at ACR Immunotherapy has opened up exciting options for cancer treatment, but it can also lead to significant complications, which specialists will assess at the American College of Rheumatology meeting.
  Medscape Medical News, October 2018
• Arthritis Tied to Higher Risk for Anxiety, Depression 'The high prevalence of symptoms of anxiety and depression among adults with arthritis warrants awareness, screening, and subsequent treatment of these conditions,' researchers say.
  Medscape Medical News, October 2018
• Depression Tied to Double the Risk for Lupus in Women A new study adds to the growing evidence that depression may be a causal risk factor for autoimmune disease.
  Medscape Medical News, September 2018
• Immunosuppressive Combo Quells Type B Insulin Resistance Combined immunosuppressive therapy is highly effective against a rare but potentially deadly and hard-to-control type of diabetes, according to a prospective study.
  Reuters Health Information, September 2018
• AstraZeneca Lupus Drug Fails to Meet Main Goal in Study AstraZeneca's experimental drug anifrolumab failed to meet its main target in a late-stage clinical study treating patients with moderate to severe lupus, the British drugmaker said on Friday.
  Reuters Health Information, August 2018
• CMR May Detect Silent Heart Disease in New-Onset SLE CMR detected subclinical cardiac disease in patients with new-onset lupus, enabling earlier treatment, a study found; larger studies are needed to assess prognosis of earlier detection.
  Medscape Medical News, August 2018
• Delayed Adverse Skin Effects After PD-1-Inhibitor Therapy Eczema, psoriasis, and lupuslike reactions can occur even months after starting or stopping these drugs, so patients need to be monitored on an ongoing basis.
  Medscape Medical News, July 2018
• Drug Combination Boosts Older Adults' Immunity in Early Trial A phase 2a randomized, placebo-controlled clinical trial showed that a combination of drugs decreases the incidence of infections, including influenza and pneumonia, in older adults.
  Medscape Medical News, July 2018
• Physician Groups: Court Ruling May Harm Vulnerable Patients The Department of Justice recently lent unexpected support to a group of Republican attorneys general who are challenging the constitutionality of the Affordable Care Act in federal court.
  Medscape Medical News, June 2018
• Lilly's Lupus Treatment Succeeds in Mid-Stage Trial Eli Lilly & Co said its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin a bigger study later this year.
  Reuters Health Information, June 2018
• EULAR 2018New Osteoarthritis Treatments Garnering Attention at EULAR Interest in osteoarthritis is growing as new treatment options emerge, and insights will be discussed at the upcoming European League Against Rheumatism Congress (EULAR).
  Medscape Medical News, June 2018
• Subcutaneous Belimumab Improves Systemic Lupus Erythematosus Outcomes
  Reuters Health Information, April 2018
• Germany's Merck Seeks Partners for Cancer and Immune System Drugs Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.
  Reuters Health Information, April 2018
• Epstein-Barr Virus Transcription Factor Implicated in Seven Autoimmune Diseases
  Reuters Health Information, April 2018
• Patient Advocacy Groups Take in Millions From Drugmakers. Is There Payback? Kaiser Health News launches 'Pre$cription for Power,' a groundbreaking database to expose Big Pharma’s ties to patient groups.
  Kaiser Health News, April 2018